[go: up one dir, main page]

CN1267456C - Process for preparing glucose-reducing sand sagebrush polysaccharide and its use - Google Patents

Process for preparing glucose-reducing sand sagebrush polysaccharide and its use Download PDF

Info

Publication number
CN1267456C
CN1267456C CN 200510002228 CN200510002228A CN1267456C CN 1267456 C CN1267456 C CN 1267456C CN 200510002228 CN200510002228 CN 200510002228 CN 200510002228 A CN200510002228 A CN 200510002228A CN 1267456 C CN1267456 C CN 1267456C
Authority
CN
China
Prior art keywords
diabetes
artemisia
hypoglycemic
preparation
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN 200510002228
Other languages
Chinese (zh)
Other versions
CN1654481A (en
Inventor
张继
侯天德
王云普
姚健
程昉
曾家豫
吴建
黄玉龙
马君义
王振恒
李芳成
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northwest Normal University
Original Assignee
Northwest Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northwest Normal University filed Critical Northwest Normal University
Priority to CN 200510002228 priority Critical patent/CN1267456C/en
Publication of CN1654481A publication Critical patent/CN1654481A/en
Application granted granted Critical
Publication of CN1267456C publication Critical patent/CN1267456C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明涉及一种以天然沙蒿种子脱去油后的废渣为原料,经过提取、分离、酶解、柱层析制备的沙蒿多糖及其制备方法和应用,其特征是用50-80%乙醇提取,氯仿和正丁醇混合液进行萃取,木瓜蛋白酶进行酶解、通过sephadex G-200柱层析而获得,用于治疗四氧嘧啶引起的化学型糖尿病,减少糖尿病对肝脏、肾脏的受损,降低血液中谷草转氨酶、谷丙转氨酶、尿素氮的含量,并能抑制糖尿病导致体重的减轻,生产工艺简单,降糖效果好,无毒副作用,使用方便,用于治疗糖尿病效果良好。The invention relates to a kind of Artemisia annua polysaccharide prepared by extracting, separating, enzymatically hydrolyzing and column chromatography using waste residue after removing oil from natural Artemisia annua seeds as raw material, and its preparation method and application, which is characterized in that it uses 50-80% Ethanol extraction, chloroform and n-butanol mixture for extraction, papain enzymatic hydrolysis, obtained through sephadex G-200 column chromatography, used to treat chemical diabetes caused by alloxan, and reduce the damage of diabetes to the liver and kidney , reduce blood aspartate aminotransferase, alanine aminotransferase, urea nitrogen content, and can inhibit weight loss caused by diabetes, simple production process, good hypoglycemic effect, no toxic side effects, easy to use, good effect for treating diabetes.

Description

一种降糖的沙蒿多糖制备方法及其应用A kind of preparation method and application of artemisia polysaccharide for hypoglycemic

技术领域technical field

本发明涉及一种以天然沙蒿种子脱去油后的废渣为原料,经过提取、分离、酶解、柱层析制备的具有降糖作用的沙蒿多糖制备方法及其应用。The invention relates to a method for preparing Artemisia annua polysaccharide with hypoglycemic effect, which is prepared by extracting, separating, enzymatically hydrolyzing and column chromatography using the waste residue after removing oil from natural Artemisia annua seeds and its application.

背景技术Background technique

糖尿病是一种与遗传因素和多种环境因素相关联的以慢性高血糖为特征的代谢紊乱综合症,是一种全球范围内的严重危害人类健康的常见疾病。近年来,全球糖尿病患病率及死亡率都呈现一个逐步上升趋势,成为当今世界医学界亟待解决和攻克的重点课题之一。常用降糖药是以合成药物为主的制剂,对肝肾有一定的损伤,不易为患者接受。Diabetes mellitus is a metabolic disorder syndrome characterized by chronic hyperglycemia associated with genetic factors and various environmental factors. It is a common disease that seriously endangers human health worldwide. In recent years, the prevalence and mortality of diabetes in the world have shown a gradual upward trend, and it has become one of the key issues to be solved and overcome in the world's medical field today. Commonly used hypoglycemic drugs are mainly synthetic drugs, which have certain damage to the liver and kidney and are not easily accepted by patients.

专利JP95/00560申请了具有降血糖作用新的吡啶型噻唑烷化合物及其盐;专利CN86104075(86104075)申请了降血糖药物--噻唑烷二酮类的制备方法,它们在治疗高血糖动物中的应用方法以及含有它们的药物配方;专利CN1252273(99121819.1)申请了新一代磺脲类降血糖药-硒代蛋氨酸铬磺脲类降血糖药的制备和应用;专利CN1465342(02112414.0)申请了一种噻唑烷盐类衍生物降血糖药物;CN1113491(95102055.2)通过选择性还原适宜的1-(2-,3-或4-硝基苯磺酰)衍生物制备具有降血糖活性的新的羟胺化合物。Patent JP95/00560 applied for a new pyridine-type thiazolidine compound and its salt with hypoglycemic effect; patent CN86104075 (86104075) applied for the preparation method of hypoglycemic drugs-thiazolidinedione, and they are effective in treating hyperglycemic animals. Application methods and pharmaceutical formulations containing them; patent CN1252273 (99121819.1) applied for the preparation and application of a new generation of sulfonylurea hypoglycemic agents-selenomethionine chromium sulfonylurea hypoglycemic agents; patent CN1465342 (02112414.0) applied for a thiazole Alkyl salt derivative hypoglycemic drug; CN1113491 (95102055.2) prepares new hydroxylamine compound with hypoglycemic activity by selectively reducing suitable 1-(2-, 3- or 4-nitrobenzenesulfonyl) derivatives.

专利US20030072822申请了一种龙蒿乙醇提取物治疗糖尿病的方法;专利US20040151783申请了一种具有降血糖作用的森林匙羹藤叶多糖成分;专利US20030054015申请了一种可兴奋交感神经的香精的成分,其中柚子油对糖尿病患者具有降血糖效果。专利US20030198697申请了一种从薏苡中提取的脂肪酸成分,具有降血糖作用。专利CN1188651(97100285.1)从野生的石莲花中提取的含有降血糖有效成分的一种高效纯天然的降血糖保健品或药品;专利CN1151303(95117499.1)申请了一种以景天科燕子掌等植物为原料提取降血糖与营养物质的新工艺;专利CN1137411(95105954.8)申请了一种由人参、蛤蚧等12种中药组成的康复胰岛降血糖的中药“康复胰岛降糖丹”及制作方法;专利CN1401318(02138749.4)从中药鬼箭羽中提取、分离具有降血糖作用的有效部位及有效成分,包含萜类、酚酸类等,具有降糖尿病小鼠血糖作用,同时影响丙二醛及超氧化物歧化酶,能够减轻或抑制糖尿病并发症的发生和发展;专利CN1456337(03128089.7)申请了一种含多个降血糖活性成分的苦瓜制品及制备方法;专利CN1306752(00101247.9)公开了一种具有降血糖作用的食用保健饼干一缮食纤维百乐饼干的配方及生产工艺。该饼干主要含有面粉、膳食纤维、活性多糖、山药、苦瓜等,经科学方法研制而成。Patent US20030072822 applied for a method of ethanol extract of tarragon to treat diabetes; patent US20040151783 applied for a polysaccharide component of Gymnema sylvestris leaf with hypoglycemic effect; Among them, grapefruit oil has a hypoglycemic effect on diabetic patients. Patent US20030198697 applied for a fatty acid component extracted from coix, which has hypoglycemic effect. Patent CN1188651 (97100285.1) extracts a kind of high-efficiency pure natural hypoglycemic health care product or medicine containing hypoglycemic active ingredients extracted from wild stone lotus; A new technology for extracting blood sugar and nutrients from raw materials; patent CN1137411 (95105954.8) applied for a Chinese medicine "Rehabilitation Pancreatic Islet Hypoglycemic Pill" composed of 12 kinds of traditional Chinese medicines such as ginseng and gecko and its production method; patent CN1401318 ( 02138749.4) Extracting and separating the effective parts and active ingredients with hypoglycemic effect from the traditional Chinese medicine Guijianyu, including terpenoids, phenolic acids, etc., which have the effect of reducing blood sugar in diabetic mice, and at the same time affect malondialdehyde and superoxide dismutase , can reduce or inhibit the occurrence and development of diabetic complications; patent CN1456337 (03128089.7) applied for a bitter melon product containing multiple hypoglycemic active ingredients and its preparation method; patent CN1306752 (00101247.9) disclosed a Edible health biscuits—the formula and production process of food fiber potluck biscuits. The biscuit mainly contains flour, dietary fiber, active polysaccharide, yam, bitter gourd, etc., and is developed through scientific methods.

专利PCT/KR98/00325申请了一种作为降血糖剂的如分子式(I)的生物类黄酮或含有同样生物类黄酮的植物提取物的降低哺乳动物血糖水平的用途;专利CN1348762(00116167.9)用苦参黄酮制备治疗糖尿病的药剂,和用苦参黄酮与黄芪多糖、人参多糖、人参总甙、麦冬多糖、天花粉多糖、桑叶总多糖有效成分中的至少一种制备治疗糖尿病的复方药剂;专利CN1389146(02138749.4)将青钱柳提取物,配以风味剂,辅助物质,并加入海藻酸钠、羧甲基纤维素、琼脂、黄原胶中两种或两种以上物质作为稳定剂,制得的降血糖、降血压、降血脂保健食品;专利CN1245060(98110398.7)将(1)L-肉碱,(2)壳聚糖,(3)富铬微生物多糖份按一定配方组合在一种高效减肥及降血糖药品或保健食品的制备方法;专利CN1398630(02136740.X)从中药材白术中提取具有降血糖活性的糖复合物、其生产方法和用途。国内外专利均未涉及沙蒿多糖为原料的降糖天然产物的制备方法及应用。Patent PCT/KR98/00325 has applied for a kind of as hypoglycemic agent as the bioflavonoid of molecular formula (I) or the purposes that the plant extract that contains same bioflavonoid reduces the blood sugar level of mammal; Patent CN1348762 (00116167.9) uses bitter Preparation of medicaments for treating diabetes from ginseng flavonoids, and preparation of compound medicaments for treating diabetes by using at least one of the active ingredients of sophora flavonoids and astragalus polysaccharides, ginseng polysaccharides, ginsenosides, Ophiopogon japonicus polysaccharides, trichosanthin polysaccharides, and mulberry leaf total polysaccharides; patent CN1389146 (02138749.4) extract of Cyclocarya paliurus, together with flavoring agent and auxiliary substances, and add two or more substances in sodium alginate, carboxymethyl cellulose, agar, and xanthan gum as stabilizers to obtain Hypoglycemic, blood pressure, and blood fat-lowering health food; patent CN1245060 (98110398.7) combines (1) L-carnitine, (2) chitosan, (3) chromium-rich microbial polysaccharides in a high-efficiency weight-loss diet according to a certain formula And the preparation method of hypoglycemic medicine or health food; the patent CN1398630 (02136740.X) extracts the sugar complex with hypoglycemic activity from the Chinese medicinal material Atractylodes Rhizoma Atractylodes Rhizome, its production method and application. None of the patents at home and abroad involve the preparation method and application of the hypoglycemic natural product made of artemisia polysaccharide as raw material.

发明内容Contents of the invention

本发明的目的是以沙蒿脱去油后的废渣为原料,经过提取、分离、酶解、柱层析等制备的一种天然的能降低血糖,并能减少糖尿病造成的对肝脏、肾脏的损伤即降低血液中谷草转氨酶、谷丙转氨酶、尿素氮的含量,以及抑制糖尿病导致体重减轻的天然生物多糖沙蒿多糖及其制备方法和应用。The purpose of the present invention is to use the waste residue after degreasing of Artemisia annua as raw material, and prepare a kind of natural can reduce blood sugar through extraction, separation, enzymolysis, column chromatography, etc., and can reduce the damage to liver and kidney caused by diabetes. The damage is to reduce the contents of aspartate aminotransferase, alanine aminotransferase and urea nitrogen in the blood, as well as the natural biological polysaccharide Artemisia polysaccharide that inhibits weight loss caused by diabetes, and its preparation method and application.

本发明的步骤如下,The steps of the present invention are as follows,

步骤1:沙蒿种子经CO2超临界萃取脱去油脂后,用水充分溶解,原料与水的比例为1∶30-50,在水溶液中加入乙醇,乙醇含量达到50-80%后静止、过夜、离心,收集沉淀,真空干燥得物质A;Step 1: After the Artemisia annua seeds are degreased by CO2 supercritical extraction, fully dissolve in water, the ratio of raw materials to water is 1:30-50, add ethanol to the aqueous solution, and let the ethanol content reach 50-80%, then stand still and stay overnight , Centrifuge, collect the precipitate, and vacuum-dry to obtain substance A;

步骤2:称取一定重量的物质A,用80-100倍重量的水溶解,在水溶液中加入木瓜蛋白酶进行酶解,再用1∶2-4氯仿和正丁醇混合液进行萃取,收集水层溶液减压浓缩、干燥得物质B,A水溶液与萃取液按体积比比例为4∶1、木瓜蛋白酶用量为24.00U/2000ml水溶液;Step 2: Weigh a certain weight of substance A, dissolve it with 80-100 times the weight of water, add papain to the aqueous solution for enzymatic hydrolysis, then extract with a 1:2-4 mixture of chloroform and n-butanol, and collect the water layer The solution was concentrated under reduced pressure and dried to obtain substance B, the volume ratio of the aqueous solution of A and the extract was 4:1, and the amount of papain was 24.00U/2000ml of aqueous solution;

步骤3:将物质B通过sephadex G-200柱层析,洗脱液为:0.05molNacl溶液,流速:8ml/h,收集层析后洗脱液每份1.5ml,洗脱液减压浓缩后放入透析袋中透析36-48h,透析液加入2-3倍量乙醇静止、过夜、离心,收集沉淀,真空干燥得纯沙蒿种子天然生物多糖。Step 3: Pass substance B through sephadex G-200 column chromatography, eluent: 0.05molNacl solution, flow rate: 8ml/h, collect 1.5ml of eluent after chromatography, concentrate under reduced pressure and release Put it into a dialysis bag for dialysis for 36-48 hours, add 2-3 times the amount of ethanol to the dialysate, let it stand overnight, centrifuge, collect the precipitate, and dry it in vacuum to obtain the natural biopolysaccharide of pure Artemisia annua seeds.

分子量、化学组成:分子量Mn约为1.42×105g/mol,第二维利系数是3.64×10-5cm3mol/g2;由L-阿拉伯糖、D-木糖、D-来苏糖、D-甘露糖、D-葡萄糖、D-半乳糖等六种单糖组成,摩尔比为0.14∶0.09∶1.51∶0.17∶0.07∶1.45,白色粉末。Molecular weight and chemical composition: the molecular weight Mn is about 1.42×10 5 g/mol, and the second Veliy coefficient is 3.64×10 -5 cm 3 mol/g 2 ; it consists of L-arabinose, D-xylose, and D-lysol Sugar, D-mannose, D-glucose, D-galactose and other six monosaccharides, the molar ratio is 0.14:0.09:1.51:0.17:0.07:1.45, white powder.

此天然生物多糖主要用于治疗化学性糖尿病,并能减少糖尿病对肝、肾的损伤等经对大鼠药理实验表明:30天喂养该制剂使高血糖动物的血糖降低13.98%,谷丙转氨酶(GPT)降低25.48%、谷草转氨酶(GOT)降低28.7%、尿素氮含量降低51.27%、显著减缓糖尿病引起的体重下降。This natural biological polysaccharide is mainly used to treat chemical diabetes, and can reduce the damage of diabetes to liver and kidney, etc. Pharmacological experiments on rats showed that feeding the preparation for 30 days reduced the blood sugar of hyperglycemic animals by 13.98%, alanine aminotransferase ( GPT) decreased by 25.48%, aspartate transaminase (GOT) decreased by 28.7%, blood urea nitrogen content decreased by 51.27%, and the weight loss caused by diabetes was significantly slowed down.

本发明的特点:本发明以沙蒿脱去油后的废渣为原料,经过提取、分离、酶解、柱层析等制备的一种天然的能降低血糖,并能减少糖尿病对肝脏、肾脏的损伤即降低血液中谷草转氨酶、谷丙转氨酶、尿素氮的含量,并能抑制糖尿病导致体重减轻的制剂。与其它降糖药相比具有生产工艺简单,降糖效果好,无毒副作用,使用方便,对I型、II型糖尿病等都有较好的疗效。The characteristics of the present invention: the present invention uses the waste residue after degreasing of Artemisia annua as raw material, and prepares a kind of natural blood sugar that can lower blood sugar and reduce the damage of diabetes to the liver and kidney through extraction, separation, enzymolysis, column chromatography, etc. Injuries are preparations that reduce the levels of aspartate aminotransferase, alanine aminotransferase, and urea nitrogen in the blood, and can inhibit weight loss caused by diabetes. Compared with other hypoglycemic drugs, it has the advantages of simple production process, good hypoglycemic effect, no toxic and side effects, convenient use, and good curative effect on type I and type II diabetes.

具体实施方式Detailed ways

实施例1:Example 1:

沙蒿种子中降糖天然产物的制备方法及其应用Preparation method and application of hypoglycemic natural product from Artemisia annua seeds

步骤1:沙蒿种子经CO2超临界萃取脱去油脂后的部分用水充分溶解(原料与水的比例为1∶30),在水溶液中加入乙醇(乙醇含量达到50%)静止、过夜、离心,收集沉淀真空干燥得物质A;Step 1: The part of Artemisia annua seeds degreased by CO2 supercritical extraction is fully dissolved in water (the ratio of raw material to water is 1:30), and ethanol is added to the aqueous solution (the ethanol content reaches 50%) to stand still, overnight, and centrifuged , collect the precipitate and dry it in vacuum to obtain substance A;

步骤2:称取一定重量的物质A用80倍重量的水溶解,在水溶解中加入木瓜蛋白酶进行酶解,再用氯仿和正丁醇(1∶2)混合液进行萃取,收集水层溶液减压浓缩、干燥得物质B,A水溶液与萃取液按体积比比例为4∶1,木瓜蛋白酶用量为24.00U/2000ml水溶液;Step 2: take a certain weight of material A and dissolve it in water with 80 times its weight, add papain to the water solution for enzymolysis, then extract with chloroform and n-butanol (1:2) mixture, collect the aqueous layer solution to reduce Concentrate under pressure and dry to obtain substance B, the volume ratio of A aqueous solution and extract is 4:1, and the amount of papain is 24.00U/2000ml aqueous solution;

步骤3:将物质B通过sephadex G-200柱层析(洗脱液为:0.05molNacl溶液,流速:8ml/h,收集层析后洗脱液每份1.5ml),洗脱液减压浓缩后放入透析袋中透析36h,透析液加入2倍量乙醇静止、过夜、离心,收集沉淀真空干燥得纯降糖天然产物。Step 3: Pass substance B through sephadex G-200 column chromatography (eluent: 0.05molNacl solution, flow rate: 8ml/h, collect 1.5ml of eluent after chromatography), and concentrate the eluent under reduced pressure Put it into a dialysis bag for dialysis for 36 hours, add 2 times the amount of ethanol to the dialysate, let it stand overnight, centrifuge, collect the precipitate and dry it in vacuum to obtain a pure hypoglycemic natural product.

降糖作用:四氧嘧啶引起的化学型糖尿病大鼠服用本品后血液中血糖、谷丙转氨酶、谷草转氨酶、尿素氮均降低结果如下表:Hypoglycemic effect: Alloxan-induced chemical diabetic rats took this product and the blood sugar, alanine aminotransferase, aspartate aminotransferase, and urea nitrogen all decreased. The results are shown in the following table:

  对照组 control group   高血糖组 High blood sugar group            高血糖组+本品     Hyperglycemia group + this product   血糖(m mol/L) Blood sugar (m mol/L)   3.77 3.77   5.71 5.71   4.48 4.48   降低13.98% 13.98% reduction   谷丙转氨酶(Iμ/L) Alanine aminotransferase (Iμ/L)   27.0375 27.0375   77.025 77.025   51.5136 51.5136   降低降低25.48% Decrease by 25.48%   谷草转氨酶(Iμ/L) Aspartate aminotransferase (Iμ/L)   146.375 146.375   230 230   165 165   降低28.7% 28.7% reduction   尿素氮(m mol/L) Burea nitrogen (m mol/L)   7.0225 7.0225   26.7425 26.7425   13.0136 13.0136   降低51.27% 51.27% reduction

体重变化:每组体重平均值见(表1),对照组体重增加,高血糖组体重明显降低,降低率为7.69%,而喂纯天然沙蒿多糖组的糖尿病大鼠个体体重略减轻,降低率为1.56%,说明其对高血糖个体体重的减轻有一定的抑制作用。Body weight change: the average weight of each group is shown in (Table 1). The weight of the control group increased, and the body weight of the hyperglycemia group decreased significantly, with a reduction rate of 7.69%. The rate is 1.56%, indicating that it has a certain inhibitory effect on the weight loss of individuals with high blood sugar.

表1  实验各组大鼠体重(g/只)  天数   1   30天   生长趋势  高血糖组   260.1   240.1   -7.69%  高血糖+沙蒿多糖   269.2   265.5   -1.56%  对照组   266.2   289   +8.56% Table 1 Body weight of rats in each experimental group (g/rat) number of days 1 30 days growth trend Hyperglycemia group 260.1 240.1 -7.69% High blood sugar + artemisinin 269.2 265.5 -1.56% control group 266.2 289 +8.56%

利用动静态光散射仪、气相色谱、红外光谱、核磁共振等表征纯降糖天然产物的分子量和化学组成。The molecular weight and chemical composition of pure hypoglycemic natural products were characterized by dynamic and static light scattering, gas chromatography, infrared spectroscopy, and nuclear magnetic resonance.

动静态光散射仪、气相色谱证实:纯降糖天然产物重均分子量Mn约为1.42×105g/mol,第二维利系数是3.64×10-5cm3mol/g2;由L-阿拉伯糖、D-木糖、D-来苏糖、D-甘露糖、D-葡萄糖、D-半乳糖等六种单糖组成,摩尔比为0.14∶0.09∶1.51∶0.17∶0.07∶1.45,白色粉末。Dynamic and static light scattering instrument and gas chromatography confirmed that the weight-average molecular weight Mn of the pure hypoglycemic natural product is about 1.42×10 5 g/mol, and the second Veliy coefficient is 3.64×10 -5 cm 3 mol/g 2 ; Composed of six monosaccharides including arabinose, D-xylose, D-lyxose, D-mannose, D-glucose, and D-galactose, the molar ratio is 0.14:0.09:1.51:0.17:0.07:1.45, white powder.

葡萄糖(Glu)用葡萄糖氧化酶法测定、谷丙转氨酶(GPT)与谷草转氨酶(GOT)分别用连续检测法测定,尿素氮(BuN)使用终点法测定等指标。仪器使用全自动生化分析仪,OLYcupus AU400型(日本)。四氧嘧啶购自sigma公司产品。Glucose (Glu) was determined by glucose oxidase method, alanine aminotransferase (GPT) and aspartate aminotransferase (GOT) were determined by continuous detection method, and urea nitrogen (BuN) was determined by endpoint method. The instrument uses a fully automatic biochemical analyzer, OLYcupus AU400 (Japan). Alloxan was purchased from sigma company.

服用本品后使四氧嘧啶引起的化学型糖尿病动物的血糖、谷丙转氨酶、谷草转氨酶、尿素氮含量均降低,表明降糖效果较好。After taking this product, the blood sugar, alanine aminotransferase, aspartate aminotransferase, and urea nitrogen content of alloxan-induced chemical diabetic animals were all reduced, indicating that the hypoglycemic effect is better.

实施例2:Example 2:

沙蒿种子中降糖天然产物的制备方法及其应用Preparation method and application of hypoglycemic natural product from Artemisia annua seeds

步骤1:沙蒿种子经CO2超临界萃取脱去油脂后的部分用水充分溶解(原料与水的比例为1∶50),在水溶液中加入乙醇(乙醇含量达到80%)静止、过夜、离心,收集沉淀真空干燥得物质A;Step 1: Part of Artemisia annua seeds degreased by CO2 supercritical extraction is fully dissolved in water (the ratio of raw material to water is 1:50), and ethanol is added to the aqueous solution (the ethanol content reaches 80%) to stand still, overnight, and centrifuged , collect the precipitate and dry it in vacuum to obtain substance A;

步骤2:称取一定重量的物质A用100倍重量的水溶解,在水溶解中加入木瓜蛋白酶进行酶解,再用氯仿和正丁醇(1∶4)混合液进行萃取,收集水层溶液减压浓缩、干燥得物质B,A水溶液与萃取液按体积比比例为4∶1、木瓜蛋白酶用量为24.00U/2000ml水溶液;Step 2: take a certain weight of material A and dissolve it in 100 times the weight of water, add papain to the water solution for enzymolysis, then extract with chloroform and n-butanol (1:4) mixture, collect the aqueous layer solution to reduce Concentrate under pressure and dry to obtain substance B, the ratio of A aqueous solution and extract is 4:1 by volume, and the amount of papain is 24.00U/2000ml aqueous solution;

步骤3:将物质B通过sephadex G-200柱层析(洗脱液为:0.05molNacl溶液,流速:8ml/h,收集层析后洗脱液每份1.5ml),洗脱液减压浓缩后放入透析袋中透析48h,透析液加入3倍量乙醇静止、过夜、离心,收集沉淀真空干燥得纯降糖天然产物。Step 3: Pass substance B through sephadex G-200 column chromatography (eluent: 0.05molNacl solution, flow rate: 8ml/h, collect 1.5ml of eluent after chromatography), and concentrate the eluent under reduced pressure Put it into a dialysis bag for dialysis for 48 hours, add 3 times the amount of ethanol to the dialysate, let it stand overnight, centrifuge, collect the precipitate and dry it in vacuum to obtain the pure hypoglycemic natural product.

大鼠试验结果与实施例1同,利用动静态光散射仪、气相色谱、红外光谱、核磁共振等表征纯降糖天然产物的分子量和化学组成与实施例1同。The results of the rat test are the same as in Example 1, and the molecular weight and chemical composition of the pure hypoglycemic natural product are the same as in Example 1.

实施例3:Example 3:

沙蒿种子中降糖天然产物的制备方法及其应用Preparation method and application of hypoglycemic natural product from Artemisia annua seeds

步骤1:沙蒿种子经CO2超临界萃取脱去油脂后的部分用水充分溶解(原料与水的比例为1∶40),在水溶液中加入乙醇(乙醇含量达到70%)静止、过夜、离心,收集沉淀真空干燥得物质A;Step 1: Part of Artemisia annua seeds degreased by CO supercritical extraction is fully dissolved in water (the ratio of raw material to water is 1:40), and ethanol is added to the aqueous solution (the ethanol content reaches 70%) to stand still, overnight, and centrifuged , collect the precipitate and dry it in vacuum to obtain substance A;

步骤2:称取一定重量的物质A用90倍重量的水溶解,在水溶解中加入木瓜蛋白酶进行酶解,再用氯仿和正丁醇(1∶3)混合液进行萃取,收集水层溶液减压浓缩、干燥得物质B,A水溶液与萃取液按体积比比例为4∶1、木瓜蛋白酶用量为24.00U/2000ml水溶液;Step 2: take a certain weight of material A and dissolve it in water with 90 times its weight, add papain in the water solution to carry out enzymolysis, then extract with chloroform and n-butanol (1:3) mixed solution, collect the aqueous layer solution to reduce Concentrate under pressure and dry to obtain substance B, the ratio of A aqueous solution and extract is 4:1 by volume, and the amount of papain is 24.00U/2000ml aqueous solution;

步骤3:将物质B通过sephadex G-200柱层析(洗脱液为:0.05molNacl溶液,流速:8ml/h,收集层析后洗脱液每份1.5ml),洗脱液减压浓缩后放入透析袋中透析36-48h,透析液加入2.5倍量乙醇静止、过夜、离心,收集沉淀真空干燥得纯降糖天然产物。Step 3: Pass substance B through sephadex G-200 column chromatography (eluent: 0.05molNacl solution, flow rate: 8ml/h, collect 1.5ml of eluent after chromatography), and concentrate the eluent under reduced pressure Put it into a dialysis bag for dialysis for 36-48 hours, add 2.5 times the amount of ethanol to the dialysate, let it stand overnight, centrifuge, collect the precipitate and dry it in vacuum to obtain the pure hypoglycemic natural product.

大鼠试验结果与实施例1同,利用动静态光散射仪、气相色谱、红外光谱、核磁共振等表征纯降糖天然产物的分子量和化学组成与实施例1同。The results of the rat test are the same as in Example 1, and the molecular weight and chemical composition of the pure hypoglycemic natural product are the same as in Example 1.

Claims (3)

1. the artemisia desertorum polysaccharide preparation method of a hypoglycemic is characterized in that: the waste residue that utilizes the natural biological sand sagebrush (Artemisia filifolia) to slough behind the oil obtains through the following step for raw material:
Step 1: the sand sagebrush (Artemisia filifolia) seed is through CO 2After supercritical extraction was sloughed grease, water fully dissolved, and the ratio of raw material and water is 1: 30-50, in the aqueous solution, add ethanol, and that ethanol content reaches is static behind the 50-80%, spend the night, centrifugal, collecting precipitation, vacuum-drying gets substance A;
Step 2: the substance A that takes by weighing certainweight, water dissolution with 80-100 times of weight, in water dissolution, add papoid and carry out enzymolysis, use 1 again: 2-4 chloroform and propyl carbinol mixed solution extract, collect that the water layer solution decompression concentrates, dry substance B, the A aqueous solution and extraction liquid ratio by volume are that 4: 1, papoid consumption are the 24.00U/2000ml aqueous solution;
Step 3: substance B is passed through sephadex G-200 column chromatography, elutriant is: 0.05molNacl solution, flow velocity: 8ml/h, every part of 1.5ml of elutriant behind the collection chromatography, put into the dialysis tubing 36-48h that dialyses behind the elutriant concentrating under reduced pressure, dialyzate add 2-3 doubly measure ethanol static, spend the night, centrifugal, collecting precipitation, vacuum-drying gets pure sand sagebrush (Artemisia filifolia) natural seed biological polyoses.
2. the artemisia desertorum polysaccharide of the preparation method of artemisia desertorum polysaccharide according to claim 1 preparation, it is characterized in that: it is made up of L-arabinose, D-wood sugar, D-lyxose, D-seminose, D-glucose, six kinds of monose of D-semi-lactosi, mol ratio was followed successively by 0.14: 0.09: 1.51: 0.17: 0.07: 1.45, weight-average molecular weight Mn was 1.42 * 10 5G/mol.
3. the application of artemisia desertorum polysaccharide according to claim 2 is characterized in that: be used for the treatment of the chemotype diabetes that tetraoxypyrimidine causes.
CN 200510002228 2005-01-18 2005-01-18 Process for preparing glucose-reducing sand sagebrush polysaccharide and its use Expired - Fee Related CN1267456C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200510002228 CN1267456C (en) 2005-01-18 2005-01-18 Process for preparing glucose-reducing sand sagebrush polysaccharide and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200510002228 CN1267456C (en) 2005-01-18 2005-01-18 Process for preparing glucose-reducing sand sagebrush polysaccharide and its use

Publications (2)

Publication Number Publication Date
CN1654481A CN1654481A (en) 2005-08-17
CN1267456C true CN1267456C (en) 2006-08-02

Family

ID=34894102

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200510002228 Expired - Fee Related CN1267456C (en) 2005-01-18 2005-01-18 Process for preparing glucose-reducing sand sagebrush polysaccharide and its use

Country Status (1)

Country Link
CN (1) CN1267456C (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100553496C (en) * 2006-06-02 2009-10-28 中国科学院长春应用化学研究所 A kind of preparation process of sand sage gelatin diet
CN101219157B (en) * 2007-11-16 2010-12-08 西北师范大学 A kind of preparation method of blood sugar lowering product
CN101240036B (en) 2008-02-26 2010-06-09 西北师范大学 A method for microwave-assisted extraction of Artemisia polysaccharides
CN100572397C (en) * 2008-05-07 2009-12-23 西北师范大学 A kind of preparation method of lily polysaccharide of strengthening immunity
CN101412762B (en) * 2008-12-10 2011-01-05 西北师范大学 Method for catalytically synthesizing sand sagebrush polysaccharide sulfate
CN102268101A (en) * 2011-08-31 2011-12-07 南京财经大学 Enzyme-assisted extraction method of high-purity porphyra polysaccharide
CN102987206A (en) * 2012-12-27 2013-03-27 上海普维健康食品有限公司 Composition capable of reducing blood glucose
CN103156865B (en) * 2013-03-14 2015-12-23 广西壮族自治区中国科学院广西植物研究所 L-arabinose is preparing the application in medicine or health product
CN106397622B (en) * 2016-10-11 2018-10-02 重庆三峡医药高等专科学校 The extraction of bulbus fritillariae cirrhosae polysaccharide and separation purifying technique
CN114644719A (en) * 2022-03-24 2022-06-21 珠海中科先进技术研究院有限公司 Hai antler polysaccharide extracting solution and preparation method and application thereof

Also Published As

Publication number Publication date
CN1654481A (en) 2005-08-17

Similar Documents

Publication Publication Date Title
EP3275456B1 (en) Pharmaceutical composition containing silibinin and pueraria root extract
CN101357952A (en) A kind of mussel polysaccharide MA with hypolipidemic activity and preparation method thereof
CN1267456C (en) Process for preparing glucose-reducing sand sagebrush polysaccharide and its use
CN113425764A (en) Application of herba cistanches Deserticolae total glycosides and echinacoside in preparing medicine for preventing and treating alcoholic liver injury and intestinal injury
CN104997883A (en) Inonotus obliquus raspberry tree red raspberry composition, inonotus obliquus raspberry tree red raspberry composite oral solution and preparation method and application thereof
CN111568945A (en) Compound cyclocarya paliurus preparation
CN112961262A (en) Passiflora edulis pericarp acidic polysaccharide, preparation method and application thereof
CN104288344B (en) Application of Pu' er tea extract in preparation of medicine or food for regulating intestinal flora and relaxing bowels
CN113694104B (en) Traditional Chinese medicine composition with protection effect on chemical liver injury and liver regeneration promotion function, preparation method and application thereof
CN107266599B (en) Flammulina velutipes polysaccharide, extraction method and application thereof in preparation of medicine for treating functional constipation
CN1965915A (en) Method for extracting bitter buckwheat flavone in high purity
CN106265717B (en) Application of the dicliptera chinensis polysaccharide in preparing prevention diabetes medicament or health products
JP3966727B2 (en) Drugs made from aged kyoto extract
CN113332395A (en) Traditional Chinese medicine composition for treating type 2 diabetes and preparation method thereof
CN106109554A (en) A kind of compositions improving insulin resistant
CN113521186B (en) Hypoglycemic drug and preparation method and application thereof
CN119185417B (en) Composition for promoting blood circulation, reducing turbidity and preventing myocardial infarction, as well as preparation method and application thereof
CN101219157B (en) A kind of preparation method of blood sugar lowering product
CN114292343B (en) A method for preparing exopolysaccharide and intracellular polysaccharide of Perennial ash and its application in regulating intestinal microbial flora and lowering blood sugar
CN101744989B (en) Method for extracting schisandra chinensis, ginseng and dwarf lilyturf root and preparation thereof
CN1919875A (en) Cryptoporus volvatus polysaccharide, preparation and application thereof
CN112121056A (en) The use of the composition of small molecule fucoidan and phycoxanthin for preparing the composition for improving non-alcoholic fatty liver
CN101040647A (en) Mulberry leaf tea and its preparing process
Al-Okbi et al. Assessment of the safety of use of certain natural anti-inflammatory agents and their effects on nutritional status in adult and growing rats
CN103301243B (en) Application of pharmaceutical composition in preparation of drugs for preventing or treating fatty liver

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20060802

Termination date: 20110118